Vol 6, Supplement 1 (February 28, 2017): Translational Cancer Research

Commentary

Commentary on “MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy”

Mathieu Derouet, Gail E. Darling

PDF Pages: S1-S2 Full Text (1753) COI Form Open Access

Association between hypomethylation of specific smoking-related CpG sites and lung cancer

Yuzuru Niibe, Atsuro Terahara, Hideomi Yamashita, Kazushige Hayakawa

PDF Pages: S3-S4 Full Text (1917) COI Form Open Access

Expelling the “perpetrators”: ovarian cancer cells discard miR-6126 through exosomes to promote survival

Kenta Masuda, Ahmed Ashour Ahmed

PDF Pages: S5-S7 Full Text (3407) COI Form Open Access

Metabolites-mitochondria-macrophages (MMM): new therapeutic avenues for inflammation and muscle atrophy

Corrado Angelini

PDF Pages: S8-S11 Full Text (4601) COI Form Open Access

A microRNA molecular signature of aggressive prostate cancer

Farhana Matin, Jyotsna Batra

PDF Pages: S12-S14 Full Text (2627) COI Form Open Access

KRAS mutations: efficacy and sensitivity of early predictive screening of cancer progression require other gene mutations in addition to KRAS

Manpreet Sambi, Myron R. Szewczuk

PDF Pages: S15-S17 Full Text (2822) COI Form Open Access

MOAP-1, UBR5 and cisplatin resistance in ovarian cancer

Scott T. Eblen, Amber Bradley

PDF Pages: S18-S21 Full Text (5232) COI Form Open Access

Immunosuppressive role of γδ T cells in cancer: the other side of the coin

Rushikesh Patil, Shalini Kashipathi Sureshbabu, Shubhada V. Chiplunkar

PDF Pages: S22-S25 Full Text (4382) COI Form Open Access

The vestibular approach in transoral thyroid surgery: proceedings within the clinical setting

Elias Karakas

PDF Pages: S26-S28 Full Text (2083) COI Form Open Access

Interaction of tumor and stromal cells in pancreatic cancer

Jochen Gaedcke, Alexander König

PDF Pages: S29-S30 Full Text (1845) COI Form Open Access

High dose Bacillus Calmette-Guerin (BCG) for urothelial carcinoma is trickier than expected

Mohammad R. Siddiqui, Piyush K. Agarwal

PDF Pages: S31-S32 Full Text (1435) COI Form Open Access

CD274 (PD-L1) genomic change: another marker for small-cell lung cancer?

Yusuke Inoue, Takafumi Suda, Haruhiko Sugimura

PDF Pages: S33-S35 Full Text (3090) COI Form Open Access

Cleaning up the environment in juvenile myelomonocytic leukemia

Lisa Deng, Rebecca J. Chan

PDF Pages: S36-S38 Full Text (1963) COI Form Open Access

Estimated risks of recurrence and mortality in lung cancer: comprehensive analysis by a population-based study

Junko Tanizaki, Hidetoshi Hayashi, Kazuhiko Nakagawa

PDF Pages: S39-S41 Full Text (2142) Open Access

Defining the subset of the patients in whom “Less is More” for hormone receptor-positive breast cancer: clinical risk vs. genomics risk

Yeon Hee Park

PDF Pages: S42-S43 Full Text (1885) COI Form Open Access

CRISPR made easy in human and murine hematopoietic precursors

Elisa ten Hacken, Michaela Gruber

PDF Pages: S44-S46 Full Text (2276) COI Form Open Access

Molecular heterogeneity of localized prostate cancer: more different than alike

Jeffrey J. Tosoian, Emmanuel S. Antonarakis

PDF Pages: S47-S50 Full Text (4744) Open Access

Early detection of lung cancer based on DNA methylation analysis in sputum and plasma

Evi Lianidou, Catherine Alix-Panabières

PDF Pages: S51-S53 Full Text (4174) COI Form Open Access

Differential crizotinib response duration among ALK fusion variants in ALK-positive non–small-cell lung cancer

Alberto Ruano-Ravina, Mariano Provencio-Pulla

PDF Pages: S54-S56 Full Text (2049) COI Form Open Access

Inhibit a kinase to degrade a histone demethylase: a candidate therapeutic approach in glioblastoma

Alba Maiques-Diaz, Tim C. P. Somervaille

PDF Pages: S57-S60 Full Text (2541) Open Access

Plasma genotyping for EGFR T790M in non-small cell lung cancer: ready for clinical practice?

Melissa Bersanelli, Francesco Gelsomino, Sebastiano Buti, Michelangelo Fiorentino, Marcello Tiseo

PDF Pages: S61-S64 Full Text (2673) COI Form Open Access

Genetic footprints of T cell exhaustion

Marcus Buggert, Johanna Tauriainen, Annika C. Karlsson

PDF Pages: S65-S67 Full Text (4005) COI Form Open Access

Shelterin genes, germ line mutations and chronic lymphocytic leukemia

Irma Slavutsky

PDF Pages: S68-S71 Full Text (3001) COI Form Open Access

Mutations in KRAS: are they a valid biomarker for pancreatic ductal adenocarcinomas diagnosis?

Vilvapathy Narayanan, Sergey R. Konstantinov, Maikel P. Peppelenbosch

PDF Pages: S72-S77 Full Text (4057) COI Form Open Access

A crowded, but still varied, space: brigatinib in anaplastic lymphoma kinase-rearranged non-small cell lung cancer

Sawsan Rashdan, David E. Gerber

PDF Pages: S78-S82 Full Text (5744) COI Form Open Access

Exportin 1/chromosome region maintenance 1 as a therapeutic target for lung cancer

Weimin Gao

PDF Pages: S83-S86 Full Text (4654) COI Form Open Access

Glioblastoma stem cells and the importance of endolysosomes to keep them in the niches

Bernard Rogister

PDF Pages: S87-S89 Full Text (1937) COI Form Open Access

The role of tumor-derived exosomes in epithelial mesenchymal transition (EMT)

Theresa L. Whiteside

PDF Pages: S90-S92 Full Text (4917) COI Form Open Access

KDM4B under hypoxia: a new targetable pathway for epithelial ovarian cancer?

Vin Yee Chung, Ruby Yun-Ju Huang

PDF Pages: S93-S95 Full Text (2377) COI Form Open Access

Proton beam therapy as a rising option in treating intrahepatic cholangiocarcinoma

Jae Woo Lee, Sang Hyub Lee

PDF Pages: S96-S98 Full Text (5112) COI Form Open Access

Editorial

Extremely low dose ¹⁸F-FDG PET imaging and its potential use for lung cancer screening

Jianhua Yan, Zhifang Wu, Sijin Li

PDF Pages: S99-S101 Full Text (2746) COI Form Open Access

Beyond immune suppression: the intrinsic function of PD-L1 in ovarian cancer and melanoma

Hengrui Zhu, Rugang Zhang

PDF Pages: S102-S103 Full Text (2551) COI Form Open Access

Neuroendocrine differentiation in prostate cancer: key epigenetic players

Karishma Gupta, Sanjay Gupta

PDF Pages: S104-S108 Full Text (9004) COI Form Open Access

Targeting the pyrimidine synthesis pathway for differentiation therapy of acute myelogenous leukemia

Yuqing Sun, Jay L. Hess

PDF Pages: S109-S111 Full Text (2533) COI Form Open Access

Oligometastatic disease in prostate cancer, a continuously changing paradigm: patient selection and treatment strategy

Andrei Fodor, Cesare Cozzarini, Claudio Fiorino, Nadia Gisella Di Muzio

PDF Pages: S112-S116 Full Text (5671) COI Form Open Access

Osimertinib: a breakthrough for the treatment of epidermal growth factor receptor mutant lung adenocarcinoma

Niki Karachaliou, eliciano Barron Barron, Santiago Viteri, Miguel Angel Molina, Rafael Rosell

PDF Pages: S117-S121 Full Text (3961) COI Form Open Access

DNA methylation biomarkers in lung cancer diagnosis: closer to practical use?

Gerd P. Pfeifer, Kemp H. Kernstine

PDF Pages: S122-S126 Full Text (8358) COI Form Open Access

Revealing the mutational landscape of APL

José Cervera, Miguel A. Sanz

PDF Pages: S127-S130 Full Text (4008) COI Form Open Access

Looking into the future (remnant liver)

Toine M. Lodewick, Frank G. Schaap, Steven W.M. Olde Damink

PDF Pages: S131-S135 Full Text (2670) COI Form Open Access

Gene signatures predictive of response to radiotherapy in prostate cancer: a new step towards precision medicine

Angela Lombardi, Anna Grimaldi, Michele Caraglia

PDF Pages: S136-S140 Full Text (2913) COI Form Open Access

Immunotherapy, checkpoint inhibitor advance to frontline non-small cell lung cancer

John Nemunaitis, Neil Senzer

PDF Pages: S141-S144 Full Text (2723) COI Form Open Access

Heparin-induced thrombocytopenia: new insights into the immune response

Benilde Cosmi

PDF Pages: S145-S148 Full Text (1881) Open Access

Subsequent treatment(s) for prostate cancer recurrence following radical prostatectomy deteriorate functional outcome and quality of life

Theo M. de Reijke

PDF Pages: S149-S150 Full Text (1662) COI Form Open Access

Moving the mountain in advanced non-small-cell lung cancer: evolving immunotherapies for a dire disease

Deepa Rangachari, Daniel B. Costa

PDF Pages: S151-S157 Full Text (5366) COI Form Open Access

Prognosis in glioblastoma: insight gained from recent prospective trials

Kara D Romano, Daniel M Trifiletti, James M Larner

PDF Pages: S158-S159 Full Text (1675) COI Form Open Access

Taming immune suppressor: application of myeloid-derived suppressor cells in anti-cancer gene therapy

Bhagelu R. Achyut, Ali S. Arbab

PDF Pages: S160-S162 Full Text (4749) COI Form Open Access

Perspective

Oxaliplatin in pre-treated patients: maybe not the match point?

Chiara Caparello, Enrico Vasile, Ingrid Garajova, Asif Ali, Elisa Giovannetti

PDF Pages: S163-S167 Full Text (2438) COI Form Open Access

Bacillus Calmette-Guérin immunotherapy—increasing dose as a means of improving therapy?

Ratha Mahendran

PDF Pages: S168-S173 Full Text (4811) COI Form Open Access

Transoral thyroidectomy—from experiment to clinical implementation

Tahar Benhidjeb, Michael Stark, Isabel Gerntke, Ospan Mynbaev, Kai Witzel

PDF Pages: S174-S178 Full Text (3305) COI Form Open Access

Is dose-dependent response to bacillus Calmette-Guérin treatment in urothelial carcinoma?

Fabricio Racca, Rafael Morales-Barrera, Joan Carles

PDF Pages: S179-S181 Full Text (1841) COI Form Open Access

Metabolic sculpting of the mitochondria, cell signaling and the cancer phenotype

Martyn A. Sharpe, Nyla Ismail, David S. Baskin

PDF Pages: S182-S188 Full Text (3879) COI Form Open Access

A core of macrophages facilitates ovarian cancer metastases

Aida Freire Valls, Ying Shen, Thomas Schmidt

PDF Pages: S189-S196 Full Text (5945) COI Form Open Access

Are cyclin-dependent kinases 4/6 inhibitors ready for prime time in estrogen-receptor positive metastatic breast cancer?

Sofia Genta, Gloria Mittica, Gaia Giannone, Eleonora Ghisoni, Giorgio Valabrega

PDF Pages: S197-S200 Full Text (2597) COI Form Open Access

The practice-changing QUARTZ trial: is there any role for whole brain radiotherapy in patients with non-small cell lung cancer and brain metastases?

Elia Sais, Javier A. Menéndez, Joaquim Bosch-Barrera

PDF Pages: S201-S204 Full Text (5812) COI Form Open Access

CDK4/6 inhibitors in advanced hormone receptor-positive breast cancer

Romualdo Barroso-Sousa, Sara M. Tolaney

PDF Pages: S205-S209 Full Text (4216) Open Access

Beyond international prognostic index: risk stratification in diffuse large B-cell lymphoma

Hongyu Gao, Zimu Gong

PDF Pages: S210-S216 Full Text (6477) COI Form Open Access

The metastatic niche in the liver: tilling the soil for pancreatic cancer progression

Alexander Hann, Bruno Sainz Jr, Patrick C. Hermann

PDF Pages: S217-S220 Full Text (3866) COI Form Open Access

Are bladder cancer patients set at risk by minimally invasive approaches to radical cystectomy?

Günter Niegisch

PDF Pages: S221-S225 Full Text (2591) COI Form Open Access

Correspondence

Exosomes: an evolving source of urinary biomarkers and an up-and-coming therapeutic delivery vehicle

Robert H. Blackwell, Carrie A. Franzen, Gopal N. Gupta

PDF Pages: S226-S228 Full Text (2654) COI Form Open Access

The prospective role of matrix metalloproteinase-2/9 and transforming growth factor beta 1 in accelerating the progression of hepatocellular carcinoma

Gang Chen, Gui-hui Qin, Yi-wu Dang, Jie Yang

PDF Pages: S229-S231 Full Text (2916) COI Form Open Access

miRNA-based signature for predicting epithelial ovarian cancer recurrence

Loris De Cecco, Marina Bagnoli, Silvana Canevari, Daniela Califano, Francesco Perrone, Sandro Pignata, Delia Mezzanzanica

PDF Pages: S232-S234 Full Text (2243) COI Form Open Access

Disclosure:

This supplement was published without any sponsorship or funding.